SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical interventions for orphan and infectious disease indications; public health, emerging infectious disease preparedness and response. H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BARRON | — |
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Budget/Appropriations BUD
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BARRON | — |
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Medicare/Medicaid MMM
Medicaid Program and Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.